Smack & Opioid Addiction in UP: Breaking the Physical Chain

The Crisis at India's Spiritual Capital

Prayagraj — the confluence of the Ganga, Yamuna, and Saraswati — draws millions of pilgrims each year. It also sits on a trafficking route for brown sugar and smack that moves through eastern Uttar Pradesh from border regions.

The result is a community dealing with one of UP's most severe opioid addiction burdens. Our clinical admissions data mirrors what district health surveys confirm: opioid use disorder (smack, brown sugar, pharmaceutical opioids like Tramadol and Codeine) accounts for approximately 35–40% of our residential admissions, with the majority of patients between the ages of 18 and 35.

Understanding what opioids do to the body — and why standard rehabilitation alone is insufficient — is essential for any family trying to help someone with opioid dependence.

What "Smack" Actually Is and Its Many Local Forms

The substance sold locally as "smack," "brown sugar," or "doda" in Prayagraj and surrounding areas is typically an impure form of heroin or diacetylmorphine, adulterated with various substances including starch, powdered milk, and in some cases, pharmaceutical opioids or fentanyl precursors.

The spectrum of opioids in clinical practice includes:

|---|---|---|

The route of administration significantly affects addiction speed and severity. Intravenous (injected) use creates the fastest, most intense dependency. Among intravenous users, there are also severe HIV and Hepatitis C transmission risks that require specific medical evaluation and counseling.

The Biology of Physical Opioid Dependency

The human brain contains its own opioid receptors — the endorphin system. Endorphins are released during exercise, social bonding, and eating. They produce feelings of well-being, reduce pain, and calm the stress response.

Opioids bind to these same receptors with far greater intensity than endorphins. With repeated use, the brain:

1. **Downregulates** (reduces the number of) its opioid receptors

2. **Reduces its own endorphin production**, having "outsourced" this function to the drug

3. Creates a state where **normal baseline functioning requires opioids** — without them, the person experiences not just absence of pleasure but active, severe physical distress

This is why opioid withdrawal is among the most physically agonizing of any substance withdrawal:

|---|---|

The physical intensity of this withdrawal is why people relapse within hours. It is not weakness — it is the body's emergency signaling that it believes it is dying.

Medication-Assisted Treatment: The Game Changer

For decades, opioid addiction was treated with willpower, isolation, and supportive care. Relapse rates were devastating. The development of evidence-based Medication-Assisted Treatment (MAT) has fundamentally changed what is possible.

Buprenorphine (Subutex / Suboxone / Buprenorphine-Naloxone)

Buprenorphine is a partial opioid agonist — it binds to opioid receptors but with lower intensity than smack, preventing withdrawal without producing the intense "high" of full opioids. Key benefits:

**Buprenorphine maintenance therapy** — using Buprenorphine for months to years rather than just acute detox — has the strongest evidence base for opioid use disorder. Long-term MAT reduces mortality, reduces HIV/Hepatitis C risk from injection, and improves quality of life significantly.

Naltrexone

An opioid antagonist — it completely blocks opioid receptors. When someone on Naltrexone uses opioids, they experience no effect. This eliminates the incentive for use. Naltrexone is used for stable patients who have completed detox and have strong motivation. It is available as daily oral tablets or monthly injectable form (Vivitrol) in India.

Methadone

Used in some centers as long-term substitution therapy. Not part of our primary protocol in Prayagraj, but we can coordinate with methadone centers where clinically appropriate.

The Special Challenge of Tramadol Addiction in UP

Tramadol (brand names: Ultram, Tramazac) deserves specific attention because it is often prescribed for pain and is not always recognized as an opioid by patients or families. Yet it binds to opioid receptors, produces dependence, and creates a withdrawal syndrome similar to other opioids.

In UP, Tramadol is widely available through chemists without proper prescription verification, making it extremely accessible for abuse. We routinely see Tramadol dependence in patients as young as 17 who began with a friend's prescription after a sports injury.

Treatment is the same evidence-based MAT approach as other opioid use disorders, with the important addition of patient education about why a "prescribed medication" became an addiction.

Intravenous Users: Harm Reduction and Additional Care

Patients who have used opioids intravenously receive additional clinical attention:

No patient is judged for their route of use. The medical need is addressed with the same care as every other patient.

Emergency Opioid Helpline: 092142 47296 (24/7)